Identification of low micromolar SARS-CoV-2 Mproinhibitors from hits identified byin silicoscreens
Abstract
Mpro, also known as 3CLpro, is the main protease of the SARS-CoV-2 coronavirus and, as such, is essential for the viral life cycle. Two studies have each screened and rankedin silicomore than one billion chemical compounds in an effort to identify putative inhibitors of Mpro. More than five hundred of the seven thousand top-ranking hits were synthesized by an external supplier and examined with respect to their activity in two biochemical assays: a protease activity assay and a thermal shift assay. Two clusters of chemical compounds with Mproinhibitory activity were identified. An additional five hundred molecules, analogues of the compounds in the two clusters described above, were also synthesized and characterizedin vitro. The study of the analogues revealed that the compounds of the first cluster acted by denaturing Mproand might denature other proteins as well. In contrast, the compounds of the second cluster targeted Mprowith much greater specificity and enhanced its melting temperature, consistent with the formation of stable Mpro-inhibitor complexes. The most active compounds of the second cluster exhibited IC50values between 4 and 7 μM and their chemical structure suggests that they could serve as leads for the development of potent Mproinhibitors.
Related articles
Related articles are currently not available for this article.